Atypical Femoral Fractures and Bisphosphonate Use

被引：118
|
作者：
Girgis, Christian M. [1 ]
Sher, Doron [1 ]
Seibel, Markus J. [1 ]
机构：
[1] Univ Sydney, Sydney, NSW 2006, Australia
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2010年 / 362卷 / 19期
关键词：
ALENDRONATE;
D O I：
10.1056/NEJMc0910389
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1848 / 1849
页数：2
相关论文
共 50 条
  • [41] Gene Network of Susceptibility to Atypical Femoral Fractures Related to Bisphosphonate Treatment
    Garcia-Giralt, Natalia
    Roca-Ayats, Neus
    Abril, Josep F.
    Martinez-Gil, Nuria
    Ovejero, Diana
    Castaneda, Santos
    Nogues, Xavier
    Grinberg, Daniel
    Balcells, Susanna
    Rabionet, Raquel
    GENES, 2022, 13 (01)
  • [42] Atypical femoral fractures bilaterally in a patient receiving bisphosphonate: a case report
    Moghnie, Alessandro
    Scamacca, Veronica
    De Fabrizio, Giovanni
    Valentini, Roberto
    CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2016, 13 (01) : 57 - 60
  • [43] Periprosthetic atypical femoral fractures exist and are associated with duration of bisphosphonate therapy
    MacKenzie, S. A.
    Ng, R. T.
    Snowden, G.
    Powell-Bowns, M. F. R.
    Duckworth, A. D.
    Scott, C. E. H.
    BONE & JOINT JOURNAL, 2019, 101B (10): : 1285 - 1291
  • [44] Increased risk for atypical fractures associated with bisphosphonate use
    Lee, Soyon
    Yin, Raynold V.
    Hirpara, Hemant
    Lee, Nancy C.
    Lee, Adrian
    Llanos, Samantha
    Phung, Olivia J.
    FAMILY PRACTICE, 2015, 32 (03) : 276 - 281
  • [45] A Case Series and Discussion on Surgical Treatment Strategy for Atypical Proximal Femoral Fractures Associated with Bisphosphonate Use
    Rocos, Brett
    Fleming, Thomas
    Harding, Karen
    Acharya, Mehool
    Riddick, Andrew
    Kelly, Mike
    CUREUS, 2018, 10 (12):
  • [46] Bisphosphonate Use and Femoral Fractures in Older Women Reply
    Park-Wyllie, Laura Y.
    Hawker, Gillian A.
    Laupacis, Andreas
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (20): : 2069 - 2069
  • [47] FDA Statement on Relationship Between Bisphosphonate Use and Atypical Subtrochanteric and Femoral Shaft Fractures: A Considered Opinion
    Rogers, Lee F.
    Taljanovic, Mihra
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 195 (03) : 563 - 566
  • [48] Risk of Atypical Femoral Fracture during and after Bisphosphonate Use
    Schilcher, Jorg
    Koeppen, Veronika
    Aspenberg, Per
    Michaelsson, Karl
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (10): : 974 - 976
  • [49] Bilateral Atypical Femoral Fractures after Bisphosphonate Treatment for Osteoporosis: A Literature Review
    Hwang, SeokJoon
    Seo, Minsu
    Lim, Dongin
    Choi, Min Suk
    Park, Jin-Woo
    Nam, Kiyeun
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (03)
  • [50] ATYPICAL FEMORAL SHAFT FRACTURES SECONDARY TO LONG-TERM BISPHOSPHONATE THERAPY
    Cardoso, R.
    Genrinho, I.
    Silva, S.
    Mazeda, C.
    Vilas Boas, P.
    Figueiredo, B.
    Brenha, J.
    Barcelos, A.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S187 - S187
12345